BIOMAT Database Logo BIOMAT Database Logo

The carcinogenic activity of 3-hydroxymethyl-1-((3-(5-nitro-2-furyl)allydidene)amino)-hydantoin in rats. 1973

S Tekeli, and C G Biava, and J M Price

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009581 Nitrofurans Compounds containing FURANS attached to a nitro group.
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005260 Female Females
D006827 Hydantoins Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS. Hydantoin,Imidazolidine-2,4-Diones,Imidazolidine 2,4 Diones
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

S Tekeli, and C G Biava, and J M Price
Carcinogenic activity of 2-(2-furyl)-3-(5-nitro-2-furyl)-acrylamide, a food additive, in mice and rats.
September 1977, Cancer letters,
S Tekeli, and C G Biava, and J M Price
Transport of the renal carcinogen 3-hydroxymethyl-1-([3-(5-nitro-2-furyl)allydidene]amino) hydantoin by renal cortex and cooxidative metabolism by prostaglandin endoperoxide synthetase.
June 1981, Cancer research,
S Tekeli, and C G Biava, and J M Price
Carcinogenic activity of 3-DI(hydroxymethyl)amino-6-(5-nitro-2-furylethenyl)-1,2,4-triazine (Panfuran-S) in male rats.
June 1977, Gan,
S Tekeli, and C G Biava, and J M Price
THE HYPOTENSIVE ACTIVITY OF N(1-(5-NITRO-2-FURYL) ETHYLIDENE)-3-AMINO-2-OXAZOLIDINONE (NF-219).
June 1964, Archives internationales de pharmacodynamie et de therapie,
S Tekeli, and C G Biava, and J M Price
[Synthesis of 3-amino-6-(1(and 2)-halo-2-(5-nitro-2-furyl)viny1)-1,2,4-triazine and 3-amino-6-(2-(5-nitro-2-furyl)ethynyl)-1,2,4-triazien and their structure-antibacterial activity].
December 1967, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Tekeli, and C G Biava, and J M Price
AF-2 [2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide].
July 1983, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
S Tekeli, and C G Biava, and J M Price
Carcinogenic effects of 3-di(hydroxymethyl)-amino-6-(5-nitro-2-furylethenyl)-1,2,4-triazine in the small intestine of Ishibashi and Wistar rats.
January 1984, Experimental pathology,
S Tekeli, and C G Biava, and J M Price
[N-(5-nitro-2-furfurylidene)-1-amino-hydantoin in urinary tract infections].
April 1957, Semaine medicale professionelle et medico-sociale,
S Tekeli, and C G Biava, and J M Price
[Carcinogenic effect of the 3-di-(hydroxymethyl-)amino-6-(5-nitro-2-furylethenyl-)1,2,4-triazines in Panfuran-S on mice].
February 1979, Onkologie,
S Tekeli, and C G Biava, and J M Price
Carcinogenicity of the antischistosomal nitrofuran trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole.
July 1984, Journal of the National Cancer Institute,
Copied contents to your clipboard!